Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features

Bing Cao(Fudan University Shanghai Cancer Center), Xiaoyan Zhou(Merck & Co., Inc., Rahway, NJ, USA (United States))
OncoTargets and Therapy
December 1, 2015
Cited by 47


Related Papers